Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0000899243-20-003714

Executive Chairman sold 60,000 shares at an average $60.90 ($3,654,088)

From the SEC's structured data for this filing

Trades in this filing

El-Hibri Fuad · Executive Chairman

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-05 Sale : show line 1 in the form −48,316 $60.66 $2,930,849 1,430,702 D
2020-02-06 Sale : show line 2 in the form −11,684 $61.90 $723,240 1,419,018 D
Open-market sales · 60,000 sh · avg $60.90 · $3,654,088
Loading xslF345X03/doc4.xml…